You are using an older browser version. Please use a supported version for the best MSN experience.

Morpen Labs to strengthen anti-allergy portfolio

#MorpenLabs #anti-allergyportfolio #allegra #USMarket #CNBCTV18 #BusinessNews #BusinessNewsToday #BusinessNewsInEnglish #ShareMarketTodayAbout CNBC-TV18: India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. Catch all your favourite shows, exclusive videos, big-ticket interviews and more here.Sushil Suri, MD of Morepen Labs said the company would be -strengthening their anti-allergy portfolio. The company will supply Allegra generic to the US market and since it is generic drug, they can start exporting it, said Suri, adding that they have got approval as a second source.You can also connect with CNBC-TV18 News OnlineCatch the latest news: CNBC-TV18 round the clock: updated with all the market action: experts on the most vital topics: to our daily newsletter: to our Channel: us on Facebook: us on Twitter:



More From CNBCTV18

image beaconimage beaconimage beacon